Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) is expected to release the results from its Phase 2b IMAGINE trial of PBT2 for the treatment of Alzheimer’s disease within the coming month. Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) shares after opening at $10.52 moved to $11.35 on last trade day and at the end of the day closed at $10.75. Company price to sales ratio in past twelve months was calculated as 1444.23 and price to cash ratio as 24.76. Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) showed a positive weekly performance of 13.76%.
Stock analysts at Needham & Company hoisted their target price on shares of Pernix Therapeutics Holdings (NYSE:PTX) from $5.00 to $5.50 in a report issued on Wednesday. Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX) shares advanced 8.87% in last trading session and ended the day on $4.91. Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX) return on equity ratio is recorded as -24.10% and its return on assets is -8.20%. Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX) yearly performance is -9.24%.
MEI Pharma, Inc. (NASDAQ:MEIP) presented at the Cowen and Company 34th Annual Health Care Conference. MEI Pharma Inc (NASDAQ:MEIP) shares moved down -6.20% in last trading session and was closed at $10.74, while trading in range of $10.55 – $11.44. MEI Pharma Inc (NASDAQ:MEIP) year to date (YTD) performance is 34.08%.
Drug firm Suven Life Sciences said it has given exclusive license to Taro Pharmaceutical Industries (NYSE:TARO) to market its Malathion Lotion, used to teat scalp infection, in US,Canada and Mexico. Taro Pharmaceutical Industries weekly performance is 9.34%. On last trading day company shares ended up $121.32. Taro Pharmaceutical Industries Ltd. (NYSE:TARO) distance from 50-day simple moving average (SMA50) is 12.18%. Analysts mean target price for the company is $85.00.